Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa

Abstract excerpt

<h4>Background</h4> South Africa was the African country most severely affected by the SARS-CoV-2 pandemic during 2020, experiencing 2 waves of infection. During the first wave, diagnostics were largely based on reverse transcription-linked PCR (RT-PCR). The Abbott PanBio antigen test was deployed during the 2nd wave which was driven by emergence of the 501Y.v2 variant. At the time of evaluation in mid-November 20...

Topics

Open a Topic to create a Post that cites this publication.

• Advanced biosensing and bioanalysis techniques
• Biosensors and Analytical Detection
• SARS-CoV-2 detection and testing

Identifiers and source

Literature Corpus work

9b3c92f0-7f6c-5ecc-afb3-ec93a6617630

DOI

10.1101/2021.02.03.21251057